SCHEMBL13305162

SCHEMBL13305162

Cc1cnn2c(NCc3ccc[n+]([O-])c3)cc(-c3cccs3)nc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 8/20 0.55
▸ CCNA2 P20248 2/20 0.55
▸ CCNA1 P78396 2/20 0.55
▸ GSK3B P49841 9/20 0.55
▸ CDK9 P50750 5/20 0.54
▸ CDK5 Q00535 5/20 0.54
▸ CDK1 P06493 4/20 0.54
▸ CCNE1 P24864 3/20 0.43
▸ GSK3A P49840 2/20 0.43
▸ CDK7 P50613 2/20 0.43
▸ TAOK1 Q7L7X3 2/20 0.43
▸ CCNT1 O60563 1/20 0.43
▸ CCNT2 O60583 1/20 0.43
▸ BRD4 O60885 1/20 0.43
▸ CCNK O75909 1/20 0.43
▸ CCNB2 O95067 1/20 0.43
▸ CCNE2 O96020 1/20 0.43
▸ CDK4 P11802 1/20 0.43
▸ CCNB1 P14635 1/20 0.43
▸ ERCC2 P18074 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13304605 0.89 CDK2 (0.55) CDK2CCNA2CCNA1GSK3BCDK9
SCHEMBL12953832 0.89 GSK3B (0.70) CDK2CCNA2CCNA1GSK3BCDK9
SCHEMBL13304917 0.85 CDK2 (0.67) CDK2CCNA2CCNA1GSK3BCDK9
SCHEMBL12048517 0.82 CDK2 (0.59) CDK2CCNA2CCNA1GSK3BCDK9
SCHEMBL13116861 0.80 CDK2 (0.66) CDK2CCNA2CCNA1GSK3BCDK9
SCHEMBL12952846 0.77 GSK3B (0.70) CDK2CCNA2CCNA1GSK3BCCNE1
SCHEMBL12953390 0.77 CDK2 (0.70) CDK2CCNA2CCNA1GSK3BCDK9
SCHEMBL12953179 0.77 CDK2 (0.80) CDK2CCNA2CCNA1GSK3BCDK9
SCHEMBL12953583 0.77 CDK2 (0.69) CDK2CCNA2CCNA1GSK3BCDK9
SCHEMBL13304680 0.74 CDK2 (0.60) CDK2CCNA2CCNA1GSK3BCDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537116-B1 PYRAZOLOPYRIMIDINES SUITABLE FOR THE TREATMENT OF CANCER DISEASES SCHERING CORP (US) 2010-06-02 — — EP disclosed
Send feedback